For press requests, please contact Jimmy Wyderko at jwyderko@economicliberties.us or 301-221-7778.


Axios: Workers taking center stage is latest sign U.S. is in new antitrust era

April 29, 2024 — Elizabeth Wilkins is quoted in coverage of the shift in antitrust focus toward labor markets, highlighting efforts to protect worker competition and wages.

DOT’s New Automatic Refund Rule is Another Big Swing Against Corporate Power in Flying

April 24, 2024 — In response to news that the U.S. Department of Transportation (DOT) has issued a final rule requiring airlines to provide automatic and fast refunds to passengers in the event of a cancellation or delay, mishandled baggage, or junk fees for services not actually provided, the American Economic Liberties Project released the following statement.

FTC’s Ban on Restrictive Non-Competes Will Boost Wages, Unleash Entrepreneurship

April 23, 2024 — In response to the release of a final rule from the Federal Trade Commission banning non-compete agreements, the American Economic Liberties Project and eleven other organizations released the following statements.

Fortune: America’s health system is still in crisis after its biggest cyberattack ever—but the ‘catastrophe’ is just a blip for the giant company that got hacked

April 23, 2024 — Benjamin Jolley is quoted describing how consolidation creates the systemic risk that led to a cyberattack on Change Healthcare, disrupting U.S. healthcare claims processing, delaying payments, and affecting millions of patient records.

Elizabeth Wilkins Joins Economic Liberties as Senior Advisor Alongside Additional Key Healthcare Policy Hires

April 23, 2024 — The American Economic Liberties Project today announced that Elizabeth Wilkins, Former Chief of Staff to the Chair and Director of the Office of Policy Planning at the FTC, will join the leading anti-monopoly group as Senior Fellow. The hire comes alongside other key additions to Economic Liberties’ staff, including healthcare experts Benjamin Jolley and Hayden Rooke-Ley, as the advocacy group continues to invest in healthcare policy research and analysis